| Per protocol (N = 30) |  | |
---|---|---|---|
R.E.N.A.L score (IQR) | 5 (4.3-7) | Â | |
Operation modality (%) | Open | 17 (56.7) | |
Robot-assisted | 12 (40) | ||
 | Retroperitoneoscope | 1 (3.3) | |
Operation time, min (IQR) | 97.5 (70–115) |  | |
Ischemic time, min (IQR) | 13 (11-17.8) | Â | |
Ischemic type (%) | Warm | 30 (100) | |
Estimated blood loss (IQR) (cc) | 100 (62.5–150) |  | |
Hospital days (IQR) | 4 (4–4) |  | |
Transfusion (%) | 0 (0) | Â | |
Conversion to Radical nephrectomy (%) | 0 (0) | Â | |
Tumor size (IQR) (cm) | 1.2 (1-1.9) | Â | |
Pathological T stage (%) | Â | Â | |
T1a | 29 (96.7) | Â | |
T1b | 1 (3.3) | Â | |
Surgical margin (%) | Negative | 29 (96.7) | |
Positive | 1 (3.3) | ||
30 days complication, clavien-dindo classification 3 or more | 2 (3.3) | Â |